The kickbacks took the form of free 'resupply services' for provider-customers who pushed their CPAP products. ResMed Inc. has agreed to pay $39.5 million to settle whistleblower allegations that the ...
ResMed Inc . (NYSE:RMD; ASX:RMD), a leading player in the sleep and respiratory care market, has demonstrated strong operational performance in recent quarters. However, the company faces potential ...
As Philips stares down an international recall of more than 2 million of its CPAP and sleep apnea machines, the respiratory devicemaker ResMed is looking to pick up the slack—but the surge in demand ...
In an effort to make high-quality sleep health solutions accessible to more Canadians, AirVoel is proud to announce exclusive discounts on its popular lineup of ResMed CPAP machines. Located at 4195 ...
ResMed is a dominant player in healthcare devices with strong margins, recurring revenues, and a near-monopoly, offering a compelling mix of value and growth. The company continually invests in R&D, ...
SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD) (ASX: RMD) today introduced the QuietAir diffuser vent elbow, for its latest continuous positive airway pressure (CPAP) full face masks: AirFit F20 with ...
ResMed may have clocked its highest-ever annual revenues in its 2023 fiscal year, but those gains seemingly weren’t enough to satisfy investors. In the days since the devicemaker reported its $4.2 ...
With big growth trending for CPAP machines and related products, the two biggest names in sleep apnea are expected to prosper this year. There's been a lot of talk about how the pandemic has adversely ...
Healthcare technology company ResMed's (NYSE: RMD) stock wasn't quite the picture of health on Wednesday. The shares lost more than 5% of their value on news of an analyst's downgrade and his new, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback